United States v. Giovonni Thomas

CourtCourt of Appeals for the Seventh Circuit
DecidedApril 30, 2021
Docket20-2683
StatusUnpublished

This text of United States v. Giovonni Thomas (United States v. Giovonni Thomas) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Giovonni Thomas, (7th Cir. 2021).

Opinion

NONPRECEDENTIAL DISPOSITION To be cited only in accordance with Fed. R. App. P. 32.1

United States Court of Appeals For the Seventh Circuit Chicago, Illinois 60604

Submitted February 23, 2021* Decided April 30, 2021

Before

FRANK H. EASTERBROOK, Circuit Judge

DAVID F. HAMILTON, Circuit Judge

THOMAS L. KIRSCH II, Circuit Judge

No. 20-2683

UNITED STATES OF AMERICA, Appeal from the United States District Plaintiff-Appellee, Court for the Central District of Illinois.

v. No. 10-cr-30046

GIOVONNI THOMAS, Richard Mills, Defendant-Appellant. Judge.

ORDER

Giovonni Thomas, an inmate at the Federal Correctional Institution in Elkton, Ohio (FCI Elkton), moved for compassionate release under the First Step Act. See 18 U.S.C. § 3582(c)(1)(A). On appeal he argues that FCI Elkton was unable to control a COVID-19 outbreak last year, and because he carries the sickle-cell gene, he is

* We have agreed to decide this case without oral argument because the briefs and record adequately present the facts and legal arguments, and oral argument would not significantly aid the court. FED. R. APP. P. 34(a)(2)(C). No. 20-2683 Page 2

particularly vulnerable to the virus. He also argues that he would be subject to a lower sentence today than when he was originally sentenced. Because the district court adequately assessed these concerns and reasonably found that Thomas did not qualify for release, we affirm.

Thomas pleaded guilty to possessing cocaine with intent to distribute, 21 U.S.C. § 841(b)(1)(C); possessing a firearm to further that crime, 18 U.S.C. § 924(c); and possessing a firearm as a felon, 18 U.S.C. § 922(g). In 2011, Thomas was sentenced to a prison term of 192 months, followed by a five-year term of supervised release. Thomas is scheduled for release in 2024.

Last year, after exhausting his administrative remedies, Thomas asked for compassionate release. Thomas filed a motion pro se, and his motion was later supplemented after the court appointed counsel for him. The district court then terminated his pro se motion but considered his supplemental filing, which raised two issues relating to the COVID-19 pandemic. First, Thomas cited, and the court accepted, information about FCI Elkton’s COVID-19 infection rates. At the time of Thomas’s supplemental motion, 240 inmates and seven staff members had active cases. Cumulatively, 815 of FCI Elkton’s 2,247 inmates had tested positive, and nine inmates had died of the virus. By the time the court ruled on Thomas’s motion, the cumulative number of inmate cases had increased to 982. Based on conditions like these, the U.S. Attorney General issued a memo declaring an emergency at the Bureau of Prisons (BOP) and allowing the BOP Director to consider transferring inmates to home confinement. See Office of Att’y Gen., Memorandum for Director of Bureau of Prisons, Increasing Use of Home Confinement at Institutions Most Affected by COVID-19 (Apr. 3, 2020), https://www.justice.gov/file/1266661/download. Despite this memo, Thomas argued that FCI Elkton administrators were not transferring medically vulnerable inmates to home confinement.

Second, Thomas cited personal health information. Thomas argued that he has the gene for sickle cell anemia and once had the disease itself. The Centers for Disease Control (CDC), he said, has found that persons with the disease are especially vulnerable to COVID-19. The government responded that Thomas does not currently have the disease, just the sickle cell trait, which Thomas conceded the CDC does not list as a risk factor for the virus. The medical literature that the government cited explained that the disease and the trait are not synonymous and that people with the trait typically live normal lives. Thomas replied with other evidence suggesting that, independent of the virus, those with the trait are susceptible to sudden respiratory No. 20-2683 Page 3

problems. Because COVID-19 affects respiration, Thomas contended that he remains vulnerable.

In addition to these pandemic-related arguments, Thomas raised that he would no longer be incarcerated if he were sentenced after the Supreme Court’s decision in Johnson v. United States, 576 U.S. 591 (2015), which altered who qualifies for a career offender designation. Therefore, as part of his compassionate release motion, Thomas urged the district court to consider that because he would not be designated a career offender if sentenced today under Johnson, he would now be subject to a lower guidelines range than the one he originally faced when sentenced in 2011.

The district court denied Thomas’s motion. It correctly noted that under § 3582(c)(1)(A), a court may reduce a sentence for “extraordinary and compelling” reasons. But, in rejecting Thomas’s pandemic-related arguments, it observed that “the mere existence of COVID-19 in society and possibility that it may spread to a particular prison alone cannot independently justify compassionate release.” It focused on whether the prison at which the movant is held is experiencing an outbreak, whether the prison is unable to control it, and whether the movant is susceptible to the virus. And for Thomas, the district court acknowledged that FCI Elkton had an outbreak that was not well controlled, but Thomas did not face heightened susceptibility from it. People like Thomas “with sickle cell trait can experience serious health issues,” the court said, but “most … live normal lives and experience no symptoms,” which “appear[ed] to be the case with the Defendant.”

The court likewise rejected Thomas’s sentencing-disparity argument. In doing so, the court expressed it was “mindful that, under the Sentencing Guidelines now in effect, the Defendant would have faced a lower guideline range and would very likely be out of prison by now.” The court noted that when Thomas was sentenced, his guidelines range was 262 to 327 months, but if he were sentenced today without the career offender designation that applied at the time, his range would be 160 to 185 months. Nevertheless, the court did not consider this “so ‘extraordinary and compelling’ as to warrant compassionate release.”

On appeal, Thomas argues that the district court did not adequately consider his arguments for compassionate release. We review the court’s decision for an abuse of discretion. See United States v. Saunders, 986 F.3d 1076, 1078 (7th Cir. 2021). We grant deference when it reasonably addressed the arguments for why the defendant satisfies § 3582(c)(1)(A)’s standard of “extraordinary and compelling.” See United States v. No. 20-2683 Page 4

Vasquez-Abarca, 946 F.3d 990, 993 (7th Cir. 2020) (citing Rita v. United States, 551 U.S. 338, 356 (2007)).

The district court did not abuse its discretion in denying Thomas’s motion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rita v. United States
551 U.S. 338 (Supreme Court, 2007)
Johnson v. United States
576 U.S. 591 (Supreme Court, 2015)
Blue Cross & Blue Shield Ass'n v. American Express Co.
467 F.3d 634 (Seventh Circuit, 2006)
United States v. Carlos Vasquez-Abarca
946 F.3d 990 (Seventh Circuit, 2020)
United States v. Tequila Gunn
980 F.3d 1178 (Seventh Circuit, 2020)
United States v. Glenn McDonald
981 F.3d 579 (Seventh Circuit, 2020)
United States v. James Saunders
986 F.3d 1076 (Seventh Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Giovonni Thomas, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-giovonni-thomas-ca7-2021.